Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-05-07

Clinical Trial Update: PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of PTK in combination with Letrozole for postmenopausal women with advanced breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)
  • PTK

Snippet

Sponsor: Washington University School of Medicine | Conditions: Breast Neoplasms | Phase 2 | Status: TERMINATED